The dyskenesias: a new therapeutic approach.
D002746:Chlorpromazine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007520:Isocarboxazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D011352:Procyclidine / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D007520:Isocarboxazid; D011352:Procyclidine; D002746:Chlorpromazine